Neuralink to Open Clinical Trials to Public
Neuralink, the brain chip company founded by Elon Musk, has recently announced that clinical trials for its technology will eventually be open to the public. However, this will only happen after the FDA-approved human trials. People are eager to see where the technology leads after Musk’s company made big announcements about its brain chip.
Recruitment for Clinical Trials
Neuralink has confirmed that recruitment for the clinical trials of brain chips will soon be open to the public. However, the company has not yet opened recruitment for the trials. Interested participants can join the patient registry on the company’s website to see if they qualify for future trials. Applicants need to answer questions such as legal age, permanent residency, along with sharing personal and health information.
Neuralink aims to use technology to aid people with unmet medical needs. The company is primarily focused on helping people with quadriplegia to control computers and mobiles with their thoughts. Quadriplegia is a condition that causes paralysis below the neck, affecting the hands and legs. Neuralink hopes that its technology will one day help people restore capabilities such as vision, motor function, speech, and more.
FDA Approves Human Trials
On May 26, Neuralink confirmed that the FDA had granted approval for the company’s clinical trials. Elon Musk congratulated the team, and the company tweeted, “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.” The approval signals an important milestone for the company as it moves forward with its work.
The recent announcements from Neuralink indicate that the company is making progress towards its goals. The opening of clinical trials to the public represents a significant step in developing the technology. The approval of human trials by the FDA also shows that the company is making strides in meeting regulatory requirements for medical devices. With further development, Neuralink’s brain chip technology could one day help people with unmet medical needs live fuller lives.